Improving The Diagnosis And Treatment Of Neurological Diseases – Dr Arun Swaminathan, University Of Nebraska Medical Center
Original Article Reference
This SciPod is a summary of
https://doi.org/10.33548/SCIENTIA608
Share Episode
About this episode
Medical conditions that affect the brain can have severe impacts on people’s lives. Many of these conditions can be difficult to treat, including epilepsy which affects the brain to cause seizures and the common form of dementia known as Alzheimer’s disease. Dr Arun Swaminathan at the University of Nebraska Medical Center specialises in the treatment of epilepsy. He also collaborates with fellow researchers to explore treatment options for Alzheimer’s disease.
This work is licensed under a Creative Commons Attribution 4.0 International License. 
What does this mean?
Share: You can copy and redistribute the material in any medium or format
Adapt: You can change, and build upon the material for any purpose, even commercially.
Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.
More episodes
Dr. Yassir Mahgoub | New Insights into Severe Depression Towards a Breakthrough in Treatment
Associate Professor Yassir Mahgoub and his team at Penn State University have uncovered an important link between melancholia – a severe form of depression that often doesn’t respond to treatment – and catatonia – a condition characterized by abnormal movements and associated with schizophrenia. The researchers analyzed case studies involving six patients who had been hospitalized for severe depression. All six patients experienced significant relief from their depressive symptoms by taking lorazepam – a drug typically used to treat catatonia. This discovery reveals a potential new avenue for treating severe, treatment-resistant depression.
Prof. Nelson Gekara | The Guardians of the Gut: A New Frontier in the Defence Against Viruses
Our gut contains a sleepless army, creating a hostile environment for pathogens, and helping to fortify our body’s immune defences. It may surprise you to learn that this army isn’t even human in nature, but is bacterial. The trillions of bacteria that naturally live in our gut, known as the gut microbiota, form an important component of our overall immunity against infectious disease. While bacteria can also cause disease, beneficial bacteria naturally colonise available spaces in our body, such as the gut, and play a key role in our immunity and physiology. Research conducted by Prof. Nelson Gekara of Stockholm University in Sweden and colleagues has revealed that these microscopic organisms play a crucial role in protecting us from viral infections, even in organs that are unconnected to the gut. Their study, published in the journal Immunity, uncovers a fascinating link between the gut microbiota and our body’s ability to fight viruses, offering new insights into immune function and the unintended consequences of antibiotic use.
Prof. Diana Jaalouk | Editing DNA and Degrading Proteins: The Tools to Achieve Precision Oncology
Cancer is a daunting healthcare challenge, and is still affecting millions worldwide, despite the enormous research resources that have been directed at finding effective treatments over the past decades. Many anti-cancer treatments remain poorly specific for the tumours they are intended to treat, and often suffer from modest efficacy and serious off-target effects. Part of the problem is the inherent variability between many tumours and their resulting unpredictable responses to standard chemotherapy. However, the latest advancements in precision oncology may be the start of a new paradigm, potentially providing targeted therapeutic payloads that can successfully address the specific and unique issues underlying a given patient’s cancer. Researchers such as Prof. Diana Jaalouk and her colleagues at the American University of Beirut in Lebanon are pioneering innovative tools that are changing the way we understand and treat this complex disease. Two remarkable recent technologies, CRISPR-Cas9 and PROteolysis TArgeting Chimeras (or PROTACs for short), are at the forefront of this precision revolution. While distinct in their approach, these tools share a common goal: targeting cancer with precision and minimizing harm to healthy cells. Together, they are set to reshape the therapeutic landscape.
Dr. Adeniyi Charles Adeola | Beyond Chickens: Unlocking the Hidden Treasures of Nigeria’s Poultry
When most of us think about poultry, our minds often turn to chickens, the staple of farms and dinner tables worldwide. However, Nigeria is home to several other fascinating types of poultry beyond the humble chicken that have played significant roles in the country’s agriculture, culture, and economy. While these poultry species are firmly embedded in the Nigerian agricultural system, the history of how and when these animals came to be domesticated and where these populations originally derived from is often obscure. Recent research conducted by Dr. Adeniyi Charles Adeola of the Chinese Academy of Sciences, and colleagues, has shed new light on three often-overlooked poultry species, the Muscovy duck, the domestic pigeon, and the helmeted guinea fowl. These birds not only offer valuable genetic resources but also hold keys to food security, sustainable farming, and biodiversity conservation.
Increase the impact of your research
• Good science communication encourages everyday people to be scientifically literate so that they can analyse the integrity and legitimacy of information.
• Good science communication encourages people into STEM-related fields of study and employment.
• Good public science communication fosters a community around research that includes both members of the public, policymakers and scientists.
• In a recent survey, 75% of people suggested they would prefer to listen to an interesting story than read it.
Step 2 SciPod script written
Step 3 Voice audio recorded
Step 4 SciPod published